Ishares Nasdaq Biotechnology (IBB) Shares Bought by IFP Advisors Inc

IFP Advisors Inc boosted its position in shares of Ishares Nasdaq Biotechnology (NASDAQ:IBB) by 0.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 125,938 shares of the financial services provider’s stock after buying an additional 777 shares during the period. Ishares Nasdaq Biotechnology accounts for approximately 0.6% of IFP Advisors Inc’s portfolio, making the stock its 19th biggest holding. IFP Advisors Inc’s holdings in Ishares Nasdaq Biotechnology were worth $13,443,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Tarbox Family Office Inc. increased its holdings in shares of Ishares Nasdaq Biotechnology by 200.0% in the fourth quarter. Tarbox Family Office Inc. now owns 1,059 shares of the financial services provider’s stock valued at $113,000 after purchasing an additional 706 shares during the period. Bedel Financial Consulting Inc. acquired a new position in shares of Ishares Nasdaq Biotechnology in the first quarter valued at approximately $119,000. Bollard Group LLC increased its holdings in shares of Ishares Nasdaq Biotechnology by 200.0% in the fourth quarter. Bollard Group LLC now owns 1,176 shares of the financial services provider’s stock valued at $126,000 after purchasing an additional 784 shares during the period. Aua Capital Management LLC increased its holdings in shares of Ishares Nasdaq Biotechnology by 200.0% in the fourth quarter. Aua Capital Management LLC now owns 1,200 shares of the financial services provider’s stock valued at $128,000 after purchasing an additional 800 shares during the period. Finally, Sterling Investment Advisors Ltd. increased its holdings in shares of Ishares Nasdaq Biotechnology by 200.0% in the fourth quarter. Sterling Investment Advisors Ltd. now owns 1,290 shares of the financial services provider’s stock valued at $138,000 after purchasing an additional 860 shares during the period. 58.25% of the stock is currently owned by institutional investors.

Ishares Nasdaq Biotechnology opened at $106.38 on Tuesday, MarketBeat Ratings reports. Ishares Nasdaq Biotechnology has a 12-month low of $94.20 and a 12-month high of $119.30.

About Ishares Nasdaq Biotechnology

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ishares Nasdaq Biotechnology (NASDAQ:IBB).

Institutional Ownership by Quarter for Ishares Nasdaq Biotechnology (NASDAQ:IBB)

Receive News & Ratings for Ishares Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ishares Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply